Pei Wu
ORCID: 0000-0001-7036-7543Also affiliated with Chang'an University, PharmAccess Group, China General Nuclear Power Corporation (China), Ministry of Housing and Urban-Rural Development
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Feng Liu, Wanyu Zhang Dan Cao, Pei Wu, Shanshan Wang, Zhangrui Xu +3 more
Papers
Driven by 5 papers — median percentile 0. Top paper: “Antitumor agents. 271: Total synthesis and evaluation of brazilein and analogs as anti-inflammatory and cytotoxic agents”.
Fang‐Rong Chang, Chiao Ting Yen, Tsong‐Long Hwang, Pei Wu, Kuo Hsiung Lee +5 more
Hsuan-Yu Chen, Pei Wu, Jau-Chen Lin, Susan L. Morris‐Natschke, Masuo Goto +6 more
Kyoko Nakagawa‐Goto, Pei Wu, Susan L. Morris‐Natschke, Yizhou Dong, Mien‐Chie Hung +5 more
Kuo Hsiung Lee, Pei Wu, Susan L. Morris‐Natschke, Kenneth F. Bastow, Qian Shi +2 more
Feng Liu, Wanyu Zhang Dan Cao, Pei Wu, Shanshan Wang, Zhangrui Xu +3 more